<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AExcess_capital</id>
	<title>Definition:Excess capital - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AExcess_capital"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Excess_capital&amp;action=history"/>
	<updated>2026-04-30T13:05:26Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Excess_capital&amp;diff=17016&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Excess_capital&amp;diff=17016&amp;oldid=prev"/>
		<updated>2026-03-15T10:01:03Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏛️ &amp;#039;&amp;#039;&amp;#039;Excess capital&amp;#039;&amp;#039;&amp;#039; is the amount of capital an [[Definition:Insurance carrier | insurance]] or [[Definition:Reinsurance | reinsurance]] company holds above the minimum required by regulators and its own internal risk models to support its current book of business. In a heavily regulated industry where [[Definition:Capital adequacy | capital adequacy]] is a precondition for operating, the concept of excess capital reflects the strategic buffer — or opportunity — that sits between what a company must hold and what it actually holds. It is not idle money; rather, it represents management&amp;#039;s capacity to pursue growth, return value to shareholders, or absorb unexpected losses without triggering regulatory intervention.&lt;br /&gt;
&lt;br /&gt;
⚙️ Determining what qualifies as &amp;quot;excess&amp;quot; depends on the applicable regulatory regime and the company&amp;#039;s own economic capital assessment. Under [[Definition:Solvency II | Solvency II]], European insurers calculate their [[Definition:Solvency capital requirement (SCR) | solvency capital requirement]] using either a standard formula or an approved internal model, and any own funds above this threshold constitute excess capital. In the United States, [[Definition:Risk-based capital (RBC) | RBC]] ratios serve a similar purpose, with companies typically targeting ratios well above the regulatory action level to maintain strong [[Definition:Credit rating | credit ratings]] from agencies such as [[Definition:AM Best | AM Best]] and S&amp;amp;P. In China, the [[Definition:C-ROSS | C-ROSS]] framework imposes its own tiered capital requirements. Once identified, excess capital can be deployed in several ways: funding organic growth by writing additional [[Definition:Premium | premium]], financing [[Definition:Mergers and acquisitions (M&amp;amp;A) | acquisitions]], investing in new business lines or technology, paying special dividends, or executing [[Definition:Share buyback | share buybacks]]. Some companies channel excess capital into affiliated [[Definition:Sidecar | sidecars]] or [[Definition:Insurance-linked securities (ILS) | ILS]] structures that allow them to support third-party risk while earning fee income.&lt;br /&gt;
&lt;br /&gt;
💡 How an insurer manages its excess capital is one of the clearest signals of strategic discipline and shareholder orientation. Markets tend to penalize companies that hoard capital without a clear deployment plan, compressing valuations due to the perceived drag on [[Definition:Return on equity (ROE) | return on equity]]. Conversely, companies that return excess capital efficiently — while retaining enough to weather tail events — are rewarded with premium valuations and investor confidence. The tension between capital conservation and capital efficiency is particularly acute after major [[Definition:Catastrophe loss | catastrophe]] years, when the industry collectively reassesses its capital needs and pricing adequacy. For [[Definition:Insurtech | insurtechs]] and growth-stage [[Definition:Managing general agent (MGA) | MGAs]] backed by external capital, the concept manifests differently: excess capital may not yet exist, and the focus is instead on reaching a point where the business generates surplus above its operating and regulatory needs. Across all market segments, excess capital remains a central variable in strategic planning, competitive positioning, and capital allocation decisions.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Capital adequacy]]&lt;br /&gt;
* [[Definition:Solvency capital requirement (SCR)]]&lt;br /&gt;
* [[Definition:Return on equity (ROE)]]&lt;br /&gt;
* [[Definition:Share buyback]]&lt;br /&gt;
* [[Definition:Risk-based capital (RBC)]]&lt;br /&gt;
* [[Definition:Capital management]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>